BioCardia Director Simon Stertzer Acquires 109,200 Shares in June 2026

This SEC Form 4 filing reports that Simon H. Stertzer, a director of BioCardia, Inc. (BCDA), acquired 109,200 shares of common stock over two days in June 2026. On June 22, 2026, Stertzer purchased 70,200 shares at a weighted average price of $0.92 per share, and on June 23, 2026, he purchased an additional 39,000 shares at a weighted average price of $1.00 per share. These purchases were made in multiple trades within price ranges of $0.90-$0.97 and $1.00-$1.01 respectively. Following these transactions, Stertzer directly owns 166,338 shares. Additionally, he has indirect beneficial ownership of 657,137 shares through various family trusts and entities including the Stertzer Family Trust (59,204 shares), Windrock Enterprises L.L.C. (591,054 shares), Stertzer Gamma Trust (777 shares), and Stertzer Holdings LLC (6,102 shares). The filing was signed by David McClung via power of attorney on June 24, 2026.